M1A.41
Other secondary chronic gout, shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary chronic gout affecting the shoulder, classified under ICD-10 code M1A.41, is a form of gout characterized by persistent joint inflammation and tophi formation in the shoulder joint. Unlike typical gout, which often impacts the big toe, this condition involves chronic symptoms that can affect shoulder mobility and cause ongoing discomfort. Gout is caused by the accumulation of uric acid crystals within joints, leading to inflammation and damage over time. When it becomes a long-standing issue influencing the shoulder, it is classified as secondary because it often results from underlying conditions that elevate uric acid levels, such as kidney disease or metabolic disorders.
Causes & Symptoms
Clinical Causes: Elevated uric acid levels in the bloodstream due to metabolic disorders Chronic kidney disease impairing uric acid excretion Diet high in purines (e.g., red meat, shellfish, alcohol) Use of certain medications that increase uric acid levels Genetic predisposition to uric acid overproduction
Key Symptoms: Persistent shoulder pain and stiffness Swelling and inflammation in the shoulder joint Presence of tophi (firm, chalky deposits under the skin around the shoulder) Limited range of motion or shoulder stiffness Recurrent flare-ups of joint discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other secondary chronic gout in the shoulder involves a combination of clinical evaluation, medical history review, blood tests, and imaging studies. Blood tests measure serum uric acid levels, although levels may fluctuate. Imaging techniques such as X-rays or ultrasound can reveal joint damage or tophi deposits. In some cases, joint aspiration may be performed to analyze synovial fluid for uric acid crystals, confirming gout. Medical history focusing on underlying conditions that can cause secondary gout is also important for accurate diagnosis.
Treatment Protocols: Management of this condition typically includes medications to lower uric acid levels, such as xanthine oxidase inhibitors (e.g., allopurinol or febuxostat), and anti-inflammatory drugs to control flare-ups. Lifestyle modifications are encouraged, such as adopting a diet low in purines, maintaining adequate hydration, and avoiding alcohol. In some cases, corticosteroid injections may be used directly into the shoulder joint to reduce inflammation. Long-term management aims to prevent future attacks, reduce tophi formation, and preserve joint function. Regular follow-up with healthcare professionals is vital to monitor uric acid levels and adjust treatment as needed.
Clinical Advice & FAQs
Billing Guidance
Is M1A.41 a billable ICD-10 code?
Yes, M1A.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.41?
Clinical documentation must specify the nature of Other secondary chronic gout, shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference